Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bioithas Woman
- Development stage
- Unknown
- Lead developer
- Bioithas
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Bioithas Woman is a probiotic nutraceutical developed by the Spanish company Bioithas SL to support women's health. The formulation contains a specific blend of live probiotic strains, including *Lacticaseibacillus rhamnosus*, *Lactiplantibacillus plantarum*, and *Kluyveromyces marxianus*, which were selected by the company's research team. In addition to the probiotics, the supplement includes essential nutrients such as iron, calcium, folic acid, and vitamin D. It is presented as a lactose-free and gluten-free capsule intended for daily oral consumption to maintain a healthy vaginal and systemic microbiome.
- Brand names
- Bioithas Woman
Beyond the preview
Go deeper on Bioithas Woman.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bioithas Woman.